Spots Global Cancer Trial Database for breast cancer stage ii
Every month we try and update this database with for breast cancer stage ii cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| The Differential Impact of Proton Beam Irradiation Versus Conventional Radiation on Organs-at-risk in Stage II-III Breast Cancer Patients | NCT03270072 | Breast Cancer S... Breast Cancer S... | 21 Years - | Massachusetts General Hospital | ||
| Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab | NCT05877859 | Breast Cancer T... Breast Cancer S... Breast Cancer S... Breast Cancer I... | 18 Years - | Emory University | ||
| Evaluation of Radiobiological Effects in Skin Toxicities for Breast Cancer Patients With Pencil Beam Scanning Proton Therapy | NCT06006806 | Breast Cancer Breast Cancer S... Breast Cancer S... Breast Cancer S... | Pencil Beam Sca... | 18 Years - | Thompson Cancer Survival Center | |
| Abbreviated MBCT for Depression in Older African American/Black Breast Cancer Survivors | NCT06336538 | Breast Cancer Breast Cancer F... Breast Cancer S... Breast Cancer S... Breast Cancer S... Mild Depression Moderate Depres... | MBCT | 65 Years - | Case Comprehensive Cancer Center | |
| Improvement of Quality of Life Through Supportive Treatments for Hormone Therapy - Related Symptoms in Women With Early Breast Cancer | NCT06407401 | ER+ Breast Canc... HER2-negative B... Breast Cancer S... Breast Cancer S... Breast Cancer S... Drug-Related Si... Musculoskeletal... | Duloxetine 60 M... Furosemide 40 m... Booklet for hea... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Patient Reported Outcomes After Oncoplastic Breast Conserving Surgery | NCT05724758 | Breast Cancer S... Breast Cancer S... Breast Cancer i... | Breast-conservi... | 18 Years - | Brust-Zentrum AG | |
| Taking AIM at Breast Cancer | NCT04720209 | Breast Cancer Breast Cancer S... Breast Cancer S... Breast Cancer S... | CARE TARE Home-Based Stre... | 18 Years - | Dana-Farber Cancer Institute | |
| Virtual Rehabilitation for Cancer Survivors | NCT05898789 | Breast Cancer, ... Colorectal Canc... Head and Neck C... Lymphoma Breast Cancer S... Breast Cancer S... Breast Cancer S... Colorectal Canc... Colorectal Canc... Head and Neck C... Head and Neck C... Lymphoprolifera... | CaRE@Home inter... | 18 Years - | University Health Network, Toronto | |
| Anlotinib Combined With Chemotherapy and Neoadjuvant Therapy for Hormone Receptor-positive HER-2 Negative Breast Cancer | NCT05558722 | Breast Cancer S... | Anlotinib | 18 Years - 70 Years | Xijing Hospital | |
| Ultrahypofractionation and Normal Tissue Toxicity | NCT05912231 | Breast Cancer Breast Cancer F... Breast Cancer S... Breast Cancer S... Myocardial Fibr... | Accelerated Pro... Accelerated Pho... | 18 Years - | Massachusetts General Hospital | |
| Quantitation of Endothelial Progenitor Cells as Markers of Tumor Angiogenesis in Breast Cancer | NCT00393341 | Breast Cancer S... Breast Cancer S... Breast Cancer S... | Blood Draw | 18 Years - | Indiana University | |
| Preventing Chemotherapy-Induced Peripheral Neuropathy With Acupuncture (PACT Trial) | NCT05528263 | Acupuncture Early-stage Bre... Chemotherapy-in... Breast Cancer S... Breast Cancer S... Breast Cancer S... | Acupuncture Nature scenery ... | 18 Years - | Dana-Farber Cancer Institute | |
| Neoadjuvant and Adjuvant Ribociclib and ET for Clinically High-risk ER+ and HER2- Breast Cancer | NCT05296746 | Breast Cancer S... | Ribociclib (neo... Chemotherapy (a... Ribociclib (adj... | 18 Years - | SOLTI Breast Cancer Research Group | |
| Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy | NCT06268665 | Breast Cancer Breast Cancer S... Breast Cancer S... Breast Cancer S... Breast Cancer S... Invasive Breast... Ovarian Cancer Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Breast Cancer S... Breast Cancer I... Breast Cancer, ... Breast Cancer, ... Breast Cancer S... Breast Cancer S... Breast Cancer S... Breast Cancer S... Cancer, Breast Tumors, Breast Mammary Cancer Mammary Carcino... Breast Carcinom... Breast Neoplasm Malignant Breas... Malignant Tumor... Cancer of Ovary Ovary Cancer Ovary Neoplasm | Tart Cherry Jui... | 18 Years - | University of California, Davis | |
| Neoadjuvant and Adjuvant Ribociclib and ET for Clinically High-risk ER+ and HER2- Breast Cancer | NCT05296746 | Breast Cancer S... | Ribociclib (neo... Chemotherapy (a... Ribociclib (adj... | 18 Years - | SOLTI Breast Cancer Research Group | |
| Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer | NCT05020860 | Breast Cancer Breast Neoplasm Breast Cancer F... Breast Cancer I... Breast Cancer S... Breast Cancer S... Triple Negative... Hormone Recepto... HER2-positive B... Triple Negative... Estrogen Recept... | Paclitaxel Carboplatin Trastuzumab Pertuzumab Doxorubicin Cyclophosphamid... Pembrolizumab Pertuzumab/Tras... | 18 Years - | Baylor Breast Care Center | |
| Preventing Chemotherapy-Induced Peripheral Neuropathy With Acupuncture (PACT Trial) | NCT05528263 | Acupuncture Early-stage Bre... Chemotherapy-in... Breast Cancer S... Breast Cancer S... Breast Cancer S... | Acupuncture Nature scenery ... | 18 Years - | Dana-Farber Cancer Institute | |
| The Differential Impact of Proton Beam Irradiation Versus Conventional Radiation on Organs-at-risk in Stage II-III Breast Cancer Patients | NCT03270072 | Breast Cancer S... Breast Cancer S... | 21 Years - | Massachusetts General Hospital | ||
| Increasing Patients' Engagement in Breast Cancer Surgery Decision-Making | NCT03766009 | Breast Cancer S... Breast Cancer S... Breast Cancer S... Breast Cancer S... | Usual Care Web-based decis... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Patient Reported Outcomes After Oncoplastic Breast Conserving Surgery | NCT05724758 | Breast Cancer S... Breast Cancer S... Breast Cancer i... | Breast-conservi... | 18 Years - | Brust-Zentrum AG | |
| Assessing the Response Rate of Neo-adjuvant Taxotere and Trastuzumab in Nigerian Women With Breast Cancer | NCT03879577 | Breast Cancer Breast Cancer F... HER2-positive B... Breast Cancer S... Breast Cancer S... | Docetaxel Herceptin FEC Tamoxifen Letrozole LHRH agonist | 18 Years - 70 Years | University of Chicago | |
| Improvement of Quality of Life Through Supportive Treatments for Hormone Therapy - Related Symptoms in Women With Early Breast Cancer | NCT06407401 | ER+ Breast Canc... HER2-negative B... Breast Cancer S... Breast Cancer S... Breast Cancer S... Drug-Related Si... Musculoskeletal... | Duloxetine 60 M... Furosemide 40 m... Booklet for hea... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Optimizing Surgical Decisions in Young Adults With Breast Cancer | NCT06275126 | Breast Cancer S... Breast Cancer S... Breast Cancer S... Breast Cancer S... | CONSYDER decisi... | 18 Years - 44 Years | Weill Medical College of Cornell University | |
| Novel Social Media Intervention For Older Br CA Patients | NCT02639208 | Breast Cancer S... Breast Cancer S... Breast Cancer S... | PatientsLikeMe ... | 60 Years - | Dana-Farber Cancer Institute | |
| Abbreviated MBCT for Depression in Older African American/Black Breast Cancer Survivors | NCT06336538 | Breast Cancer Breast Cancer F... Breast Cancer S... Breast Cancer S... Breast Cancer S... Mild Depression Moderate Depres... | MBCT | 65 Years - | Case Comprehensive Cancer Center | |
| Abbreviated MBCT for Depression in Older African American/Black Breast Cancer Survivors | NCT06336538 | Breast Cancer Breast Cancer F... Breast Cancer S... Breast Cancer S... Breast Cancer S... Mild Depression Moderate Depres... | MBCT | 65 Years - | Case Comprehensive Cancer Center | |
| Evaluating Mass Spectrometry And Intraoperative MRI In The Advanced Multimodality Image Guided Operating Suite (Amigo) In Breast-Conserving Therapy | NCT02335671 | Early Stage Bre... Breast Cancer S... Breast Cancer S... | Intra-operative... Mass Spectromet... | 18 Years - 75 Years | Dana-Farber Cancer Institute | |
| The Effectiveness of Psychological Interventions in Psycho-neuroendocrine-immune Network in Breast Cancer Survivors | NCT05406531 | Breast Cancer F... Breast Cancer S... Breast Cancer S... Breast Cancer S... | Mindfulness-Bas... Positive Psycho... Autogenic Train... | 18 Years - | Masaryk University | |
| Anlotinib Combined With Chemotherapy and Neoadjuvant Therapy for Hormone Receptor-positive HER-2 Negative Breast Cancer | NCT05558722 | Breast Cancer S... | Anlotinib | 18 Years - 70 Years | Xijing Hospital | |
| Feasibility of a Remotely-Delivered Yoga Intervention on Cognitive Function in Breast Cancer Survivors | NCT05180656 | Breast Cancer Breast Cancer S... Breast Cancer S... Breast Cancer S... | Yoga Interventi... | 18 Years - | University of Toronto | |
| Preventing Chemotherapy-Induced Peripheral Neuropathy With Acupuncture (PACT Trial) | NCT05528263 | Acupuncture Early-stage Bre... Chemotherapy-in... Breast Cancer S... Breast Cancer S... Breast Cancer S... | Acupuncture Nature scenery ... | 18 Years - | Dana-Farber Cancer Institute | |
| Positron Emission Tomograph(PET) Imaging Explores the Role of SF-DEVD-2 in Monitoring Tumor Efficacy | NCT05828238 | Breast Cancer S... Breast Cancer S... Solid Tumor | [18F]SF-DEVD-2 [18F]-FDG | 18 Years - 70 Years | Affiliated Hospital of Jiangnan University | |
| Anlotinib Combined With Chemotherapy and Neoadjuvant Therapy for Hormone Receptor-positive HER-2 Negative Breast Cancer | NCT05558722 | Breast Cancer S... | Anlotinib | 18 Years - 70 Years | Xijing Hospital | |
| A Study of Oleogel-S10 Gel for the Treatment of Radiation Dermatitis in People With Breast Cancer | NCT05190770 | Breast Cancer Breast Cancer S... Breast Cancer S... Breast Cancer S... Breast Cancer S... Breast Cancer S... | Triamcinolone A... Oleogel-S10 | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Improvement of Quality of Life Through Supportive Treatments for Hormone Therapy - Related Symptoms in Women With Early Breast Cancer | NCT06407401 | ER+ Breast Canc... HER2-negative B... Breast Cancer S... Breast Cancer S... Breast Cancer S... Drug-Related Si... Musculoskeletal... | Duloxetine 60 M... Furosemide 40 m... Booklet for hea... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Adjuvant Chemoradiation and Biomarkers of Response in High-risk Breast Cancer | NCT05288777 | Breast Cancer Breast Cancer S... Breast Cancer S... Breast Cancer S... | T-DM1 Capecitabine External Beam R... External Beam R... | 18 Years - | University of Virginia | |
| Novel Social Media Intervention For Older Br CA Patients | NCT02639208 | Breast Cancer S... Breast Cancer S... Breast Cancer S... | PatientsLikeMe ... | 60 Years - | Dana-Farber Cancer Institute | |
| Evaluation of Radiobiological Effects in Skin Toxicities for Breast Cancer Patients With Pencil Beam Scanning Proton Therapy | NCT06006806 | Breast Cancer Breast Cancer S... Breast Cancer S... Breast Cancer S... | Pencil Beam Sca... | 18 Years - | Thompson Cancer Survival Center | |
| Assessing the Response Rate of Neo-adjuvant Paclitaxel (Taxol) in Nigerian Women With Breast Cancer | NCT03058939 | Breast Cancer Breast Cancer S... Breast Cancer S... | Paclitaxel Perjeta Herceptin SC Tamoxifen Letrozole LHRH agonist FEC Carboplatin | 18 Years - 70 Years | University of Chicago | |
| Study the Usefulness of Bio-impedance Spectroscopy in the Early Assessment of Breast Cancer Related Lymphoedema | NCT01599039 | Lymphedema Breast Cancer S... Early Disease O... | 18 Years - | Nij Smellinghe Hosptial | ||
| Axillary Reverse Mapping in Preventing Lymphedema in Patients With Breast Cancer Undergoing Axillary Lymph Node Dissection | NCT03927027 | Breast Cancer S... Breast Cancer S... Breast Cancer S... | Isosulfan Blue Axillary Lymph ... Mapping Quality-of-Life... Questionnaire A... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Study of Cardiopulmonary Exercise Testing in Women Who Have HER2-Positive Breast Cancer With Mild Cardiotoxicity | NCT05036252 | Breast Cancer HER2-positive B... HER2-positive M... Breast Cancer S... Breast Cancer S... Breast Cancer S... Breast Cancer S... Cardiotoxicity | Cardiopulmonary... Echocardiogram Echocardiograph... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Positron Emission Tomograph(PET) Imaging Explores the Role of SF-DEVD-2 in Monitoring Tumor Efficacy | NCT05828238 | Breast Cancer S... Breast Cancer S... Solid Tumor | [18F]SF-DEVD-2 [18F]-FDG | 18 Years - 70 Years | Affiliated Hospital of Jiangnan University | |
| Novel Social Media Intervention For Older Br CA Patients | NCT02639208 | Breast Cancer S... Breast Cancer S... Breast Cancer S... | PatientsLikeMe ... | 60 Years - | Dana-Farber Cancer Institute | |
| A Study of Oleogel-S10 Gel for the Treatment of Radiation Dermatitis in People With Breast Cancer | NCT05190770 | Breast Cancer Breast Cancer S... Breast Cancer S... Breast Cancer S... Breast Cancer S... Breast Cancer S... | Triamcinolone A... Oleogel-S10 | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Safety of Lower Scalp Cooling Temperature to Prevent Hair Loss From Chemotherapy in Breast Cancer Patients | NCT04180579 | Breast Cancer Breast Cancer S... Breast Cancer S... Breast Cancer S... | PAXMAN Scalp Co... | 18 Years - 75 Years | Memorial Sloan Kettering Cancer Center | |
| Study the Usefulness of Bio-impedance Spectroscopy in the Early Assessment of Breast Cancer Related Lymphoedema | NCT01599039 | Lymphedema Breast Cancer S... Early Disease O... | 18 Years - | Nij Smellinghe Hosptial | ||
| Stress and Immunity Breast Cancer Project | NCT03578627 | Breast Cancer S... Breast Cancer S... | BioBehavioral I... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Neoadjuvant Chemotherapy With Docetaxel and Gemcitabine in Locally Advanced Breast Cancer | NCT01352494 | Breast Cancer S... Breast Cancer S... | docetaxel gemcitabine | 20 Years - 70 Years | Korean Breast Cancer Study Group |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
